Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

JU INSIGHT Evolution of Bosniak IIF Renal Cysts and Impact of the 2019 Bosniak Classification

By: Félix Couture, MD, Centre Hospitalier de l’Université de Montréal, Quebec, Canada Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada; Sarah Hadj-Mimoune, MD, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada; Stéphane Michael, MD, Centre Hospitalier de l’Université Laval, Quebec, Canada; Teodora Boblea Podasca, MD, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada; Maxime Noël-Lamy, MD, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada; Patrick O. Richard, MD, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada | Posted on: 20 Apr 2023

Couture F, Hadj-Mimoune S, Michael S, Podasca TB, Noël-Lamy M, Richard PO. Evolution of Bosniak IIF renal cysts and impact of the 2019 Bosniak classification. J Urol. 2023;209(4):694-700.

Study Need and Importance

Bosniak IIF (BIIF) renal cysts currently require cumbersome radiological follow-up, given a risk of upgrading to more complex cysts traditionally reported at around 10%-15%. Recent studies have suggested that the risk of upgrading may be lower than previously thought. Also, the impact of the revised 2019 Bosniak classification on the diagnosis and follow-up of such lesions has yet to be assessed in a real-world population.

What We Found

Through a cohort of 181 BIIF renal cysts with a median follow-up of approximately 4 years, we identified only 4 radiological progressions (2%), of which only 1 was found to be a malignant cyst (see Table). No malignant or suspicious progression occurred beyond 36 months of follow-up. When applying the 2019 Bosniak classification to our cohort, we reduced the amount of initial BIIF diagnoses by 76%, without any detrimental impact on the diagnosis and follow-up of suspicious lesions.

Table. Radiological and Clinical Outcomes of Bosniak IIF Cysts

Radiological evolution
Cyst size
Increased, No. (%) 73 (45)
Size increase, median (IQR), mm 4 (2-9)
Decreased, No. (%) 63 (38)
Size decrease, median (IQR), mm 3 (1-7)
Stable, No. (%) 28 (17)
Cyst classification, No. (%)
Stable BIIF 140 (85)
Downgrade to BI 2 (1.1)
Downgrade to BII 16 (10)
Upgrade to BIII 2 (1.1)
Upgrade to BIV 2 (1.1)
Spontaneous involution 1 (0.55)
Clinical outcomes
Symptomatic cyst, No. (%)
Pain 1 (0.55)
Hematuria 1 (0.55)
Surgical excision, No. (%)
Partial nephrectomy 3 (1.7)
Radical nephrectomy 2 (1.1)
Benign pathology 4 (2.2)
Malignant pathology 1 (papillary type 1 RCC, F2, pT1a)
Abbreviations: B, Bosniak; IQR, interquartile range; RCC, renal cell carcinoma.

Limitations

Limitations include the lack of assessment of interobserver agreement between radiologists, as well as the varying imaging quality throughout the 18-year study period. A total of 55 patients were excluded because of insufficient follow-up. Given the retrospective nature of our study, there was no standardized follow-up protocol in our cohort.

Interpretation for Patient Care

Many renal cysts (76%) classified as BIIF using the previous Bosniak classification could be classified as Bosniak II using the 2019 classification and be spared from imaging follow-up, avoiding important costs, radiation, and patient anxiety. No BIIF cyst had a significant progression beyond 36 months, which may help physicians decide how long to pursue follow-up. The very low rate of upgrading in BIIF cysts (2%) should also guide the counseling of patients diagnosed with such lesions.

advertisement

advertisement